Fig. 7

A schematic diagram depicting the possible mechanism underlying the inhibitory effects of baicalein on fibronectin (FN)-induced epithelial–mesenchymal transition (EMT) in breast cancers
A schematic diagram depicting the possible mechanism underlying the inhibitory effects of baicalein on fibronectin (FN)-induced epithelial–mesenchymal transition (EMT) in breast cancers